C K Mlambo1, R M Warren, X Poswa, T C Victor, A G Duse, E Marais. 1. Clinical Microbiology and Infectious Disease, National Health Laboratory Services, University of the Witwatersrand, Johannesburg, Gauteng, South Africa.
Abstract
SETTING: The epidemiology of extensively drug-resistant tuberculosis (XDR-TB), an emerging threat to TB control, is not well understood. OBJECTIVE: To gain insight into the genotypic population structure of XDR Mycobacterium tuberculosis strains in South Africa using a molecular approach and thereby determine whether XDR-TB is mainly acquired or transmitted. DESIGN: Sputum isolates from patients with multidrug-resistant tuberculosis (MDR-TB) were submitted to the National Referral Laboratory for second-line drug susceptibility testing. The XDR-TB isolates were spoligotyped and these data were compared to the geographic origin of the isolate. RESULTS: Of the 699 MDR-TB isolates submitted for testing between June 2005 and December 2006, 101 (17%) patients had a culture that was resistant to either ofloxacin or kanamycin, and 41 (6%) were resistant to both drugs (XDR-TB). Spoligotyping of the XDR-TB isolates identified 17 genotypes. As a result of the high genotypic diversity and geographical distribution, we estimate that between 63% and 75% of cases developed XDR-TB through acquisition. CONCLUSION: Acquisition of extensive drug resistance appears to be the primary mechanism driving the XDR-TB epidemic in South Africa. This urgent TB control issue has to be addressed to prevent the spread of this potentially incurable disease.
SETTING: The epidemiology of extensively drug-resistant tuberculosis (XDR-TB), an emerging threat to TB control, is not well understood. OBJECTIVE: To gain insight into the genotypic population structure of XDR Mycobacterium tuberculosis strains in South Africa using a molecular approach and thereby determine whether XDR-TB is mainly acquired or transmitted. DESIGN: Sputum isolates from patients with multidrug-resistant tuberculosis (MDR-TB) were submitted to the National Referral Laboratory for second-line drug susceptibility testing. The XDR-TB isolates were spoligotyped and these data were compared to the geographic origin of the isolate. RESULTS: Of the 699 MDR-TB isolates submitted for testing between June 2005 and December 2006, 101 (17%) patients had a culture that was resistant to either ofloxacin or kanamycin, and 41 (6%) were resistant to both drugs (XDR-TB). Spoligotyping of the XDR-TB isolates identified 17 genotypes. As a result of the high genotypic diversity and geographical distribution, we estimate that between 63% and 75% of cases developed XDR-TB through acquisition. CONCLUSION: Acquisition of extensive drug resistance appears to be the primary mechanism driving the XDR-TB epidemic in South Africa. This urgent TB control issue has to be addressed to prevent the spread of this potentially incurable disease.
Authors: Bourahima Kone; Anou M Somboro; Jane L Holl; Bocar Baya; Antieme Acg Togo; Yeya Dit Sadio Sarro; Bassirou Diarra; Ousmane Kodio; Robert L Murphy; William Bishai; Mamoudou Maiga; Seydou Doumbia Journal: Int J Mol Epidemiol Genet Date: 2020-06-15
Authors: Ben J Marais; Charmaine K Mlambo; Nalin Rastogi; Thierry Zozio; Adriano G Duse; Thomas C Victor; Else Marais; Robin M Warren Journal: J Clin Microbiol Date: 2013-04-03 Impact factor: 5.948
Authors: Michel Kiréopori Gomgnimbou; Edgar Abadia; Jian Zhang; Guislaine Refrégier; Stefan Panaiotov; Elizabeta Bachiyska; Christophe Sola Journal: J Clin Microbiol Date: 2012-07-18 Impact factor: 5.948
Authors: Marisol Ocampo; Hernando Curtidor; Magnolia Vanegas; Manuel A Patarroyo; Manuel E Patarroyo Journal: Chem Biol Drug Des Date: 2014-07-10 Impact factor: 2.817
Authors: Alistair D Calver; Alecia A Falmer; Megan Murray; Odelia J Strauss; Elizabeth M Streicher; Madelene Hanekom; Thelma Liversage; Mothusi Masibi; Paul D van Helden; Robin M Warren; Thomas C Victor Journal: Emerg Infect Dis Date: 2010-02 Impact factor: 6.883
Authors: Thomas R Ioerger; Sunwoo Koo; Eun-Gyu No; Xiaohua Chen; Michelle H Larsen; William R Jacobs; Manormoney Pillay; A Willem Sturm; James C Sacchettini Journal: PLoS One Date: 2009-11-05 Impact factor: 3.240